Clinical Section: Research Article

Kowall B.a· Rathmann W.b

Author affiliations

aInstitute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Essen, Germany
bInstitute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany

Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent/Cloud Rent for 48h to view Buy Cloud Access for unlimited viewing via different devices Synchronizing in the ReadCube Cloud Printing and saving restrictions apply Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview

Received: October 28, 2021
Accepted: April 10, 2022
Published online: May 13, 2022

Number of Print Pages: 9
Number of Figures: 1
Number of Tables: 4

ISSN: 0304-324X (Print)
eISSN: 1423-0003 (Online)

For additional information: https://www.karger.com/GER

Abstract

Aims: Diabetes management requires cognitive abilities. Unfortunately, diabetes is a risk factor for cognitive decline. However, the effects of diabetes in persons with reduced cognitive reserves are unclear. We aimed to examine whether the effects of diabetes and education on cognitive skills simply add up or deviate from simple additivity. Methods: We used data from waves 1 to 7 (except wave 3) of the Survey of Health, Ageing, and Retirement in Europe (SHARE) collected between 2004 and 2017. SHARE includes 140,000 persons aged ≥50 years from 28 European countries and Israel. Diabetes was assessed by self-report and education was coded according to the International Standard Classification of Education levels. Verbal fluency, immediate, and delayed memory were assessed using standard tests. Interaction between diabetes and education was estimated from interaction contrasts and from interaction terms in adjusted regression models. Results: At baseline, cognitive performance declined in the order “no diabetes/high education” > “diabetes/high education” > “no diabetes/low education” > “diabetes/low education” for all three tests – e.g., the first group named 21.4 ± 7.2, the fourth group 14.6 ± 6.1 animals in a minute in the test of verbal fluency. Interaction contrasts and regression coefficients of interaction terms were close to zero, showing that the effects of diabetes and education on cognitive performance added up without interaction both in cross-sectional and longitudinal analyses. Conclusion: We have observed no interaction between education and diabetes on cognitive skills. Yet, people with diabetes and low education showed poor cognitive performance and should receive particular support in managing diabetes.

© 2022 S. Karger AG, Basel

References Cheng G, Huang C, Deng H, Wang H. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J. 2012;42:484–91. Zhang J, Chen C, Hua S, Liao H, Wang M, Xiong Y, et al. An updated meta-analysis of cohort studies: diabetes and risk of Alzheimer’s disease. Diabetes Res Clin Pract. 2017;124:41–7. You Y, Lou Z, Chen Y, Xu Y, Qin J, Guo S, et al. The prevalence of mild cognitive impairment in type 2 diabetes mellitus patients: a systematic review and meta-analysis. Acta Diabetol. 2021;58:671–85. Palta P, Schneider AL, Biessels GJ, Touradji P, Hill-Briggs F. Magnitude of cognitive dysfunction in adults with type 2 diabetes: a meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains. J Int Neuropsychol Soc. 2014;20:278–91. Reijmer YD, van den Berg E, Ruis C, Kappelle LJ, Biessels GJ. Cognitive dysfunction in patients with type 2 diabetes. Diabetes Metab Res Rev. 2010;26:507–19. Van Duinkerken E, Ryan CM. Diabetes mellitus in the young and the old: effects on cognitive functioning across the life span. Neurobiol Dis. 2020;134:104608. Callisaya ML, Beare R, Moran C, Phan T, Wang W, Srikanth VK. Type 2 diabetes mellitus, brain atrophy and cognitive decline in older people: a longitudinal study. Diabetologia. 2019;62:448–58. Taylor CA, Bouldin ED, Greenlund KJ, McGuire LC. Comorbid chronic conditions among older adults with subjective cognitive decline, United States, 2015–2017. Innov Aging. 2020;4:igz045. Hill NL, Bhargava S, Brown MJ, Kim H, Bhang I, Mullin K, et al. Cognitive complaints in age-related chronic conditions: a systematic review. PLoS One. 2021;16(7):e0253795. Papunen S, Mustakallio-Könönen A, Auvinen J, Timonen M, Keinänen-Kiukaanniemi S, Sebert S. The association between diabetes and cognitive changes during aging. Scand J Prim Health Care. 2020;38:281–90. Pelimanni E, Jehkonen M. Type 2 diabetes and cognitive functions in middle age: a meta-analysis. J Int Neuropsychol Soc. 2019;25(2):215–29. Tuligenga RH, Dugravot A, Tabák AG, Elbaz A, Brunner EJ, Kivimäki M, et al. Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study. Lancet Diabetes Endocrinol. 2014;2:228–35. Feil DG, Zhu CW, Sultzer DL. The relationship between cognitive impairment and diabetes self-management in a population-based community sample of older adults with Type 2 diabetes. J Behav Med. 2012;35:190–9. Sinclair AJ, Girling AJ, Bayer AJ. Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. All Wales Research into Elderly (AWARE) Study. Diabetes Res Clin Pract. 2000;50:203–12. Tomlin A, Sinclair A. The influence of cognition on self-management of type 2 diabetes in older people. Psychol Res Behav Manag. 2016;9:7–20. Punthakee Z, Miller ME, Launer LJ, Williamson JD, Lazar RM, Cukierman-Yaffee T, et al. Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial. Diabetes Care. 2012;35:787–93. Pena-Gonzáles P, Mondragón-Maya A, Silva-Pereyra J, Roa-Rojas P. Cognitive reserve and executive functions in adults with type 2 diabetes. J Diabetes Res. 2020;2020:7941543. Corraini P, Olsen M, Pedersen L, Dekkers OM, Vandenbroucke JP. Effect modification, interaction and mediation: an overview of theoretical insights for clinical investigators. Clin Epidemiol. 2017;9:331–8. Börsch-Supan A, Brandt M, Hunkler C, Kneip T, Korbmacher J, Malter F, et al. Data resource profile: the Survey of Health, Ageing and Retirement in Europe (SHARE). Int J Epidemiol. 2013;42:992–1001. SHARE: Survey of Health, Ageing and Retirement in Europe. Available form: http://www.share-project.org/home0.html (accessed October 20, 2021). Yaffe K, Bahorik AL, Hoang TD, Forrester S, Jacobs DR Jr, Lewis CE, et al. Cardiovascular risk factors and accelerated cognitive decline in midlife: the CARDIA Study. Neurology. 2020;18(95):e839–46. Iniguez-Berrozpe T, Elboy C, Flecha A, Marcaletti F. Benefits of adult education participation for low educated women. Adult Education Quarterly. 2019;70:64–88. Spauwen PJ, Köhler S, Verhey FR, Stehouwer CD, van Boxtel MP. Effects of type 2 diabetes on 12-year cognitive change: results from the Maastricht Aging Study. Diabetes Care. 2013;36:1554–61. Zheng F, Yan L, Yang Z, Zhong B, Xie W. HbA1c, diabetes and cognitive decline: the English Longitudinal Study of ageing. Diabetologia. 2018;61:839–48. Biessels GJ, Despa F. Cognitive decline and dementia in diabetes: mechanisms and clinical implications. Nat Rev Endocrinol. 2018;14:591–604. Rajan KB, Arvanitakis Z, Lynch EB, McAninch EA, Wilson RS, Weuve J, et al. Cognitive decline following incident and preexisting diabetes mellitus in a population sample. Neurology. 2016;87:1681–7. Vincent C, Hall PA. Executive function in adults with type 2 diabetes: a meta-analytic review. Psychosom Med. 2015 Jul–Aug;77(6):631–42. Campbell JM, Stephenson MD, de Courten B, Chapman I, Bellman SM, Aromataris E. Metformin use associated with reduced risk of dementia in patients with diabetes: a systematic review and meta-analysis. J Alzheimers Dis. 2018;65(4):1225–36. Esiri MM, Chance SA. Cognitive reserve, cortical plasticity and resistance to Alzheimer’s disease. Alzheimers Res Ther. 2012;4:7. Primozic S, Tavcar R, Avbelj M, Dernovsek MZ, Oblak MR. Specific cognitive abilities are associated with diabetes self-management behaviour among patients with type 2 diabetes. Diabetes Res Clin Pract. 2012;95:48–54. Carmel JF, Tarnus E, Cohn JS, Bourdon E, Davignon J, Bernier L. High expression of apolipoprotein E impairs lipid storage and promotes cell proliferation in human adipocytes. J Cell Biochem. 2009;106:608–17. Nouwen A, Winkley K, Twisk C, Lloyd CE, Peyrot M, Ismail K, et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia. 2010;53:2480–6. Manschot SM, Brands AM, van der Grond J, Kessels RP, Algra A, Kappelle LJ, et al. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes. 2006;55:1106–13. Nooney JG, Kirkman MS, Bullard KM, White Z, Meadows K, Campione JR, et al. Identifying optimal survey-based algorithms to distinguish diabetes type among adults with diabetes. J Clin Transl Endocrinol. 2020;21:100231. Article / Publication Details

First-Page Preview

Received: October 28, 2021
Accepted: April 10, 2022
Published online: May 13, 2022

Number of Print Pages: 9
Number of Figures: 1
Number of Tables: 4

ISSN: 0304-324X (Print)
eISSN: 1423-0003 (Online)

For additional information: https://www.karger.com/GER

Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.